Centessa Pharmaceuticals plc American Depositary Shares

TCG Crossover Management increased its stake in Centessa Pharmaceuticals by 245,664 shares in Q3, valuing the transaction at $38.1 million. The fund now holds over 3.1 million shares, making Centessa its fifth-largest holding, driven by promising early neurological drug data.

Centessa Pharmaceuticals has priced a public offering of 11,627,907 American Depositary Shares at $21.50 per share, expecting to raise approximately $250 million to support its clinical-stage pharmaceutical development.

Centessa Pharmaceuticals (CNTA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results. Take-Two reported third-quarter total net bookings of $1.34 billion, down 3% year-over-year. The company also revised its 2024 net bookings forecast to $5.25 billion and $5.3 billion, down from $5.45 billion and $...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.